Jeanette Lundin
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Pilot Study on Intermittent Ibrutinib in Patients With Advanced-phase Chronic Lymphocytic Leukemia (CLL) (NCT04771507) | Jeanette Lundin | 2018-02-23 |
Track Jeanette Lundin automatically
Every clearance here is in the API, with alerts when new ones post.